España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
West Pharmaceutical Servs
WST
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$331.40
4.39
1.34%
At close: -
$331.20
-0.20
-0.06%
After Hours: Dec 20, 4:08 PM EDT
Get Report
Comment
West Pharmaceutical Servs (WST) Forecast
News
Earnings
West Pharmaceutical Servs (WST) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for West Pharmaceutical Servs (NYSE:WST) Stock
West Pharmaceutical Servs Stock (NYSE: WST)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, December 20, 2024
Looking Into West Pharmaceutical Servs's Recent Short Interest
Benzinga Insights
Friday, December 13, 2024
B of A Securities Maintains Buy on West Pharm...
Benzinga Newsdesk
Wolfe Research Initiates Coverage On West Pha...
Benzinga Newsdesk
Thursday, December 12, 2024
West Pharmaceutical Services shares are tradi...
Benzinga Newsdesk
UBS Upgrades West Pharmaceutical Servs to Buy...
Benzinga Newsdesk
Monday, November 18, 2024
Cameco, Applied Digital, West Pharmaceutical And More On CNBC's 'Final Trades'
Avi Kapoor
Friday, November 08, 2024
Looking Into West Pharmaceutical Servs's Recent Short Interest
Benzinga Insights
Wednesday, November 06, 2024
Peering Into West Pharmaceutical Servs's Recent Short Interest
Benzinga Insights
Thursday, October 24, 2024
West Pharmaceutical's Q3 Performance Shows Rising Demand For Syringes, Company Boosts Annual Forecast And Dividend
Vandana Singh
UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
This Is What Whales Are Betting On West Pharmaceutical Servs
Benzinga Insights
West Pharmaceutical Services shares are tradi...
Benzinga Newsdesk
West Pharmaceutical Services Forecasts Full-Y...
Benzinga Newsdesk
West Pharmaceutical Services Updates Full-Yea...
Benzinga Newsdesk
West Pharmaceutical Services Approves Q4 2024...
Benzinga Newsdesk
West Pharmaceutical Servs Q3 2024 Adj. EPS $1...
Benzinga Newsdesk
Wednesday, October 23, 2024
Earnings Outlook For West Pharmaceutical Servs
Benzinga Insights
Monday, October 14, 2024
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
Benzinga Insights
Thursday, August 29, 2024
Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Friday, August 16, 2024
S&P 500, Nasdaq 100 Mark Seventh Straight Positive Session, Strongest Week Since October 2023: Friday's Top Movers
Piero Cingari
Sunday, July 28, 2024
Ford, Stellantis And Dell Are Among Top 12 Large Cap Losers Last Week (July 21-July 27): Are The Others In Your Portfolio?
Lekha Gupta
Thursday, July 25, 2024
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
West Pharmaceutical Services shares are tradi...
Benzinga Newsdesk
West Pharmaceutical Services Expects 2024 Adj...
Benzinga Newsdesk
West Pharmaceutical Services Updates Full-Yea...
Benzinga Newsdesk
West Pharmaceutical Servs Q2 2024 Adj EPS $1....
Benzinga Newsdesk
Tuesday, July 02, 2024
How Is The Market Feeling About West Pharmaceutical Servs?
Benzinga Insights
Friday, June 21, 2024
Reasons to Hold West Pharmaceutical in Your Portfolio Now
Zacks
Friday, June 07, 2024
Peering Into West Pharmaceutical Servs's Recent Short Interest
Benzinga Insights
Wednesday, May 29, 2024
West Pharmaceutical Announced Today That It W...
Benzinga Newsdesk
Tuesday, May 14, 2024
How Is The Market Feeling About West Pharmaceutical Servs?
Benzinga Insights
Thursday, April 25, 2024
West Pharmaceutical Q1 Earnings Beat, HVP Sales Weak
Zacks
West Pharmaceutical Services Raises Full-year...
Benzinga Newsdesk
West Pharmaceutical Services Reaffirms Full-Y...
Benzinga Newsdesk
West Pharmaceutical Servs Q1 2024 Adj EPS $1....
Benzinga Newsdesk
Tuesday, March 26, 2024
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
Benzinga Insights
Friday, February 23, 2024
Mark Eric Green Expands Holdings With $288K West Pharmaceutical Servs Stock Options Acquisition
Benzinga Insights
Insider Activity Spotlight: Silji Abraham Acquires In West Pharmaceutical Servs Stock Options
Benzinga Insights
Capitalizing In Growth Prospects, Banks Kimberly MacKay Acquires In West Pharmaceutical Servs Stock Options
Benzinga Insights
Cindy ReissClark Exhibits Confidence With An Acquisition Of West Pharmaceutical Servs Stock Options
Benzinga Insights
Chad Winters Expands Holdings With West Pharmaceutical Servs Stock Options
Benzinga Insights
Thursday, February 15, 2024
S&P Reclaims 5,000 As Disappointing Retail Sales Put Fed Cuts Back On Track, Small Caps Shine: What's Driving Markets Thursday?
Piero Cingari
Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
West Pharmaceutical's 2024 Outlook Cautious, Analysts Remain Optimistic
Vandana Singh
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
Benzinga Insights
West Pharmaceutical Services shares are tradi...
Benzinga Newsdesk
West Pharmaceutical Services Expects 2024 Sal...
Benzinga Newsdesk
West Pharmaceutical Servs Q4 Adjusted EPS $1....
Benzinga Newsdesk
Earnings Scheduled For February 15, 2024
Benzinga Insights
Tuesday, February 13, 2024
Keybanc Maintains Overweight Rating for West Pharmaceutical Servs: Here's What You Need To Know
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch